Insulin Delivery Using Microneedles in Type 1 Diabetes

Conditions:		Type 1 Diabetes Mellitus
Purpose:		The goal of this study is to determine if microneedles can effectively and painlessly deliver insulin to children and young adults with type 1 diabetes.
Study Summary:
Criteria:		Inclusion Criteria: - ≥ 8 years of age - <19 years of age - T1D for at least 2 years - Uses a conventional, FDA-approved insulin pump for the past year - Uses Lispro insulin - Mean hemoglobin A1C ≤ 8.5 % for the past year - Body mass index ≤ 85th percentile for age - Understand and be willing to adhere to the study protocol Exclusion Criteria: - T2D - Acanthosis nigricans - Clinically significant major organ system disease - On glucocorticoid therapy - Insulin requirement ≥ 150 U/day - Illness on the day of the study - Cognitive impairment (IQ < 85 or > 2 grades behind age-appropriate grade) - Pregnant or breast-feeding (if female).
NCT ID:		NCT00837512
Primary Contact:		Nicholas Raviele, BS Phone: 404-727-3189 Email: nicholas.raviele@emory.edu
Backup Contact:		Email: efelner@emory.edu Eric Felner, MD, MSCR Phone: 404-727-9811
Location Contact:		Atlanta, Georgia 30322 United States Nicholas Raviele, BS Phone: 404-727-3189 Email: nicholas.raviele@emory.edu Site Status: Recruiting

Data Source:		ClinicalTrials.gov
Date Processed:		May 18, 2013
Modifications to this listing:		Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"

First Name:

Last Name:

Email Address:

Confirm Email:

Daytime Phone (eg. 555-555-5555):

City:

State:

Zip Code:

Best Time to Call:

Morning	Afternoon	Evening
Please contact me by email instead of calling.

Questions/Comments:

I have read and agree with the Privacy Policy

I have reviewed the eligibility criteria and believe I am eligible for this clinical trial

I would like to be notified about new clinical trials.